These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 24205707

  • 1. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K.
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [Abstract] [Full Text] [Related]

  • 2. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A, Sugaya T, Kimura K.
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K.
    Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
    [Abstract] [Full Text] [Related]

  • 10. Renal L-type fatty acid--binding protein in acute ischemic injury.
    Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T.
    J Am Soc Nephrol; 2007 Nov; 18(11):2894-902. PubMed ID: 17942962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery.
    Katagiri D, Doi K, Honda K, Negishi K, Fujita T, Hisagi M, Ono M, Matsubara T, Yahagi N, Iwagami M, Ohtake T, Kobayashi S, Sugaya T, Noiri E.
    Ann Thorac Surg; 2012 Feb; 93(2):577-83. PubMed ID: 22269724
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T, Sugaya T, Node K, Ueda Y, Koide H.
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
    Nakamura T, Sato E, Amaha M, Kawagoe Y, Maeda S, Yamagishi S.
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):122-7. PubMed ID: 21946392
    [Abstract] [Full Text] [Related]

  • 20. Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S.
    Metabolism; 2011 Feb; 60(2):260-4. PubMed ID: 20189611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.